News for Charles River Laboratories Stock (CRL)

Charles River (CRL) to Support Cure AP-4's Clinical Trials

Zacks Investment Research • 09/12/22

Charles River Laboratories: A 'Picks And Shovels' Biomedical Play, Now Attractively Priced

Seeking Alpha • 09/10/22

Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration

Business Wire • 09/06/22

Why Is Charles River (CRL) Down 10.7% Since Last Earnings Report?

Zacks Investment Research • 09/02/22

Charles River Laboratories Expands Contract Vivarium Space on West Coast

Business Wire • 08/23/22

Charles River (CRL) Business Hurt by Macro and FX Headwinds

Zacks Investment Research • 08/16/22

Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product

Business Wire • 08/09/22

10 Growth Stocks Analysts Say You'll Be Glad You Bought

Investors Business Daily • 08/08/22

Charles River Laboratories International, Inc. (CRL) CEO James Foster on Q2 2022 Results - Earnings Call Transcript

Seeking Alpha • 08/03/22

Charles River (CRL) Q2 Earnings Top Estimates, 2022 View Cut

Zacks Investment Research • 08/03/22

Charles River Laboratories (CRL) Beats Q2 Earnings Estimates

Zacks Investment Research • 08/03/22

Charles River Laboratories Announces Second-Quarter 2022 Results

Business Wire • 08/03/22

Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks Investment Research • 07/27/22

These 2 Stocks May Be Recession-Proof

The Motley Fool • 07/11/22

Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call

Business Wire • 07/11/22

Here's Why Investors Should Retain Charles River (CRL) Now

Zacks Investment Research • 07/05/22

Charles River (CRL) Signs saRNA-Based Vaccine Manufacture Deal

Zacks Investment Research • 06/28/22

Charles River Laboratories Announces Opening of U.K. Manufacturing Facility

Business Wire • 06/28/22

Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine

Business Wire • 06/23/22

Charles River Laboratories: High-Quality Company At A Fair Price

Seeking Alpha • 06/22/22

Charles River (CRL) Prospers Internationally Amid FX Headwind

Zacks Investment Research • 06/21/22

Charles River (CRL) to Create New Gene Therapy for Hemophilia A

Zacks Investment Research • 06/14/22

Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A

Business Wire • 06/13/22

Charles River Labs stock slides 6% premarket after company issues profit warning for Q2

Market Watch • 06/08/22

Charles River Laboratories to Participate in Jefferies and William Blair Conferences

Business Wire • 06/06/22